Drug profile · INN
pramipexole dihydrochloride
PRAMIPEXOLE DIHYDROCHLORIDE
pramipexole dihydrochloride (PRAMIPEXOLE DIHYDROCHLORIDE) is a d2-like dopamine receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — pramipexole dihydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 4
- Data quality
- 0.84
Quick answer
pramipexole dihydrochloride (PRAMIPEXOLE DIHYDROCHLORIDE) is a d2-like dopamine receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
D2-like dopamine receptor agonist
Primary target: D2-like dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is pramipexole dihydrochloride?
pramipexole dihydrochloride (PRAMIPEXOLE DIHYDROCHLORIDE) is a d2-like dopamine receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pramipexole dihydrochloride?
PRAMIPEXOLE DIHYDROCHLORIDE is a marketed brand name for pramipexole dihydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pramipexole dihydrochloride?
pramipexole dihydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.